4-Propylsulfanyl-butylamine | 1153080-48-8

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 4-Propylsulfanyl-butylamine
• 英文别名: 4-propylsulfanylbutan-1-amine
• CAS: 1153080-48-8
• 化学式: C₇H₁₇NS
• 分子量: 147.285
• InChiKey: BAGQLVMIVMSQQY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  9
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  51.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-Propylsulfanyl-butylamine 在 三乙胺 、 间氯过氧苯甲酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 1.58h， 生成 1-isothiocyanato-4-(propylsulfinyl)butane
  参考文献：
  名称：

  Synthesis and biological evaluation of sulforaphane derivatives as potential antitumor agents

  摘要：

  A series of sulforaphane derivatives were synthesized and evaluated in vitro for their cytotoxicity against five cancer cell lines (HepG2, A549, MCF-7, HCT-116 and SH-SY5Y). The pharmacological results showed that many of the derivatives displayed more potent cytotoxicity than sulforaphane (SFN). Furthermore, SFN and derivative 85 could induce cell cycle arrest at S or G2/M phase and cell apoptosis. SFN and 85 exhibited time- and dose-dependent activation on Nrf2 transcription factor, and 85 acted as a more potent Nrf2 inducer than SFN. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.03.045
• 作为产物：
  描述：

  2-(4-(propylthio)butyl)isoindoline-1,3-dione 在 一水合肼 作用下， 以 甲醇 为溶剂， 生成 4-Propylsulfanyl-butylamine
  参考文献：
  名称：

  Synthesis and biological evaluation of sulforaphane derivatives as potential antitumor agents

  摘要：

  A series of sulforaphane derivatives were synthesized and evaluated in vitro for their cytotoxicity against five cancer cell lines (HepG2, A549, MCF-7, HCT-116 and SH-SY5Y). The pharmacological results showed that many of the derivatives displayed more potent cytotoxicity than sulforaphane (SFN). Furthermore, SFN and derivative 85 could induce cell cycle arrest at S or G2/M phase and cell apoptosis. SFN and 85 exhibited time- and dose-dependent activation on Nrf2 transcription factor, and 85 acted as a more potent Nrf2 inducer than SFN. (C) 2013 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2013.03.045

文献信息

• PIPERIDINE DERIVATIVES AS NK1 ANTAGONISTS
  申请人：OPKO Health, Inc.

  公开号：EP3269713A1

  公开（公告）日：2018-01-17

  A compound having the general structure shown in Formula I: or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.

  具有式 I 所示一般结构的化合物： 或其药学上可接受的盐和/或溶解物，可用于治疗由 NK1 受体介导的疾病或病症，例如各种生理紊乱、症状或疾病，包括呃逆、抑郁、焦虑和咳嗽。
• US4180575A
  申请人：——

  公开号：US4180575A

  公开（公告）日：1979-12-25